These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9183140)

  • 21. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
    J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.
    Glazer WM; Morgenstern H; Doucette JT
    J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A summary of current knowledge of tardive dyskinesia.
    Baldessarini RJ
    Encephale; 1988 Sep; 14 Spec No():263-8. PubMed ID: 2905654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder.
    Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano R; O'Gorman C; Harrigan RH
    Pharmacotherapy; 2010 Feb; 30(2):127-35. PubMed ID: 20099987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.
    Ernst M; Devi L; Silva RR; Gonzalez NM; Small AM; Malone RP; Campbell M
    Psychopharmacol Bull; 1993; 29(2):221-7. PubMed ID: 8290669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Fundam Clin Pharmacol; 2007 Oct; 21(5):521-9. PubMed ID: 17868205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Psychopharmacology of autism].
    Chabrol H; Bonnet D; Roge B
    Encephale; 1996; 22(3):197-203. PubMed ID: 8767048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration.
    Gao XM; Hashimoto T; Cooper TB; Tamminga CA
    J Neural Transm (Vienna); 1997; 104(1):97-104. PubMed ID: 9085197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dyskinesias subside off all medication in a boy with autistic disorder and severe mental retardation.
    Brasić JR; Barnett JY; Aisemberg P; Ahn SC; Nadrich RH; Kaplan D; Ahmad R; Mendonça Mde F
    Psychol Rep; 1997 Dec; 81(3 Pt 1):755-67. PubMed ID: 9400068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should autistic children be treated with haloperidol?
    Ornitz EM
    Am J Psychiatry; 1985 Jul; 142(7):883-4. PubMed ID: 3893168
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism.
    Malone RP; Waheed A
    Drugs; 2009; 69(5):535-48. PubMed ID: 19368416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of Haldol (haloperidol) long-term intoxication.
    Gerace E; Salomone A; Pellegrino S; Vincenti M
    Forensic Sci Int; 2012 Feb; 215(1-3):121-3. PubMed ID: 21371832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptic-induced acute dyskinesias in rhesus monkeys.
    Porsolt RD; Jalfre M
    Psychopharmacology (Berl); 1981; 75(1):16-21. PubMed ID: 6117919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children.
    Anderson LT; Campbell M; Adams P; Small AM; Perry R; Shell J
    J Autism Dev Disord; 1989 Jun; 19(2):227-39. PubMed ID: 2663834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal models of tardive dyskinesias.
    Klawans HL; Goetz CG; Carvey P
    Clin Neuropharmacol; 1983 Jun; 6(2):129-35. PubMed ID: 6133617
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of haloperidol on learning and behavior in autistic children.
    Campbell M; Anderson LT; Small AM; Perry R; Green WH; Caplan R
    J Autism Dev Disord; 1982 Jun; 12(2):167-75. PubMed ID: 7174605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tardive Tourette syndrome in an autistic patient after long-term neuroleptic administration.
    Stahl SM
    Am J Psychiatry; 1980 Oct; 137(10):1267-9. PubMed ID: 6106393
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.